Meeting
2011 ASCO Annual Meeting
An analysis of vitamin D (Vit D) and serum estrogens in postmenopausal (PM) breast cancer (BC) patients receiving aromatase inhibitors (AIs).
Authors
D. W. Cescon
Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
D. W. Cescon , M. Ennis , P. A. Ganz , S. Beddows , F. Z. Stanczyk , S. S. Sridhar , P. J. Goodwin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 29: 2011 (suppl; abstr 596)
Abstract #
596
Poster Bd #
8F
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Estrogen levels in premenopausal (prem) patients (pts) with hormone-receptor positive (HR+) early breast cancer (BC) receiving adjuvant triptorelin (Trip) plus exemestane (E) or tamoxifen (T) in the SOFT trial: SOFT-EST substudy.
First Author: Meritxell Bellet
Poster
2011 ASCO Annual Meeting
Effects of body mass index (BMI) on plasma levels of estrone sulfate (ES) in postmenopausal women with breast cancer (BC) during letrozole (L) treatment.
First Author: G. Lunardi
Poster
2015 ASCO Annual Meeting
Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls.
First Author: Kathy Pan
Poster
2013 ASCO Annual Meeting
Periodontal health in early-stage postmenopausal breast cancer survivors on aromatase inhibitors.
First Author: L. Susan Taichman